News Quantified

PTCT – ptc therapeutics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference [Yahoo! Finance]

PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

PTC Therapeutics (NASDAQ:PTCT) was upgraded by analysts at Wall Street Z

6.0%

BEAT

-9.9%

BEAT

13.7%

BEAT

9.3%

BEAT

Royal Bank Of Canada

Form 4 PTC THERAPEUTICS, INC. For: Jan 08 Filed by: Utter Christine Marie

Form 4 PTC THERAPEUTICS, INC. For: Jan 08 Filed by: Pauwels Eric

Form 4 PTC THERAPEUTICS, INC. For: Jan 08 Filed by: Golden Lee Scott

Form 4 PTC THERAPEUTICS, INC. For: Jan 08 Filed by: Boulding Mark Elliott

Form 4 PTC THERAPEUTICS, INC. For: Jan 08 Filed by: Klein Matthew B.

Top News Gainers

2/6 Biogen Stock Rockets On Key Patent Win — Is It Time To Buy Shares? [Investor's Business Daily] 10.5%

3/4 PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "hold" rating re-affirmed by analysts at Barclays PLC. They now have a $51.00 price target on the stock. 9.3%

10/29 PTC Therapeutics' (PTCT) CEO Stuart Peltz on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 7.9%

5/8 PTC Therapeutics to Participate at Upcoming Investor Conferences 7.9%

3/18 Form 4 PTC THERAPEUTICS, INC. For: Mar 16 Filed by: SCHMERTZLER MICHAEL 6.2%

6/17 PTC Therapeutics, Inc. (NASDAQ: PTCT) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. 5.9%

3/18 Form SEC STAFF LETTER PTC THERAPEUTICS, INC. 5.7%

10/2 Risdiplam Spinal Muscular Atrophy Data Demonstrating Continued Benefit Presented at World Muscle Society Congress 5.6%

3/30 PTC Therapeutics, Inc. (NASDAQ: PTCT) was downgraded by analysts at TheStreet from a "c-" rating to a "d" rating. 5.5%

4/17 PTC Therapeutics Announces New Leadership Appointments 4.8%

Top News Decliners

3/16 PTC Therapeutics Announces Management Change -19.5%

3/11 PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -11.4%

9/17 PTC Therapeutics Announces Proposed Public Offering of Common Stock -11.3%

4/29 PTC Therapeutics Q1 2020 Earnings Preview [Seeking Alpha] -9.4%

3/2 Form 8-K PTC THERAPEUTICS, INC. For: Mar 02 -5.8%

4/30 Q1/2020 3/31/2020 EPS -1.810 ZacksConsensus -1.080 ActVsEst (0.730) - Miss -5.7%

9/30 PTC Therapeutics, Inc. (NASDAQ: PTCT) was given a new $62.00 price target on by analysts at Citigroup Inc. They now have a "buy" rating on the stock. -4.7%

8/5 PTC Therapeutics Expands Presence in New Jersey by Securing State-of-the-Art Biologics Facility -4.6%

1/13 PTC Therapeutics Provides Corporate Update and Highlights Pipeline Progress at 2020 J.P. Morgan Healthcare Conference -4.2%

6/13 Form 8-K PTC THERAPEUTICS, INC. For: Jun 12 -4.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day